Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs
Recruiting
Observational Study
Cervical Cancer
Cervical Intraepithelial Neoplasia (CIN)
Risk Factors
Conservative Management
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 46
- Sex
- Female
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Nikola Janovska · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The primary aim of this study is to develop a recommended clinical practice guideline for managing women with HPV HR (high-risk human papillomavirus) positivity and cervical lesions. Additionally, in collaboration with the Bioptic Laboratory, the study will analyze the integration of HPV HR testing into screening programs for women aged 35, 45, and 55, with a focus on optimizing management strateg…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Informed Consent
* cervical biopsy - HG lesion
* Age: 18-46 years
* colposcopicaly visible transformation zone
* HPV: Unvaccinated
* cytology all except AIS, adenocarcinoma, squamous cell carcinoma, AGC NEO
Exclusion Criteria:
* cytology AIS, AGC NEO, adenocarcinoma, squamou…
Contacts